RecruitingNCT07323784
NTX-1472 in Social Anxiety Disorder
This study is recruiting in the United States. It is testing NTX-1472 for anxiety.
In United StatesAnxietyOtherFrom 18 Years to 65 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
RecruitingNCT07573176
Seltorexant as Monotherapy in Adults and Elderly people with Major Depressive Disorder
This study is recruiting in the United States. It is testing seltorexant for depression.
In United StatesDepressionOtherFrom 18 Years to 74 Years
RecruitingNCT07615426
Aticaprant for schizophrenia
This study is recruiting in the United States. It is testing aticaprant for schizophrenia.
In United StatesSchizophreniaOtherFrom 18 Years to 55 Years
RecruitingNCT06696755
Adverse Events and Change for Bipolarity
This study is recruiting in the United States. It is testing adverse Events and Change for Bipolarity.
In United StatesBipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
RecruitingNCT07145918
Adverse Events, Change for schizophrenia
This study is recruiting in the United States. It is testing adverse Events, Change for schizophrenia.
In United StatesSchizophreniaOtherFrom 18 Years to 65 Years
RecruitingNCT04777357
Change for depression
This study is recruiting in the United States and in Russia. It is testing change for depression.
In United StatesBipolarity, DepressionDrugFrom 10 Years to 17 Years
RecruitingNCT07276997
Change in Disease Activity and Adverse Events of Oral Icalcaprant in adults with Major Depressive Disorder
This study is recruiting in the United States. It is testing change for depression.
In United StatesDepressionOtherFrom 18 Years to 65 Years
RecruitingNCT05511363
KarXT for Schizophrenia
This study is recruiting in the United States, in France, in the United Kingdom, .... It is testing KarXT for Schizophrenia.
In United StatesSchizophreniaOtherFrom 55 Years to 90 Years
RecruitingNCT06126224
KarXT for Schizophrenia
This study is recruiting in the United States, in Canada, in the United Kingdom, .... It is testing KarXT for Schizophrenia.
In United StatesSchizophreniaOtherFrom 55 Years to 90 Years
RecruitingNCT06540833
ITI-1284 for Schizophrenia
This study is recruiting in the United States, in Bulgaria, in Croatia, .... It is testing ITI-1284 for Schizophrenia.
In United StatesSchizophreniaOtherOver 55 Years
RecruitingNCT06887192
ML-007C-MA for Schizophrenia
This study is recruiting in the United States, in France, in Canada, .... It is testing ML-007C-MA for Schizophrenia.
In United StatesSchizophreniaOtherFrom 55 Years to 90 Years
RecruitingNCT06524830
VLS-01 Buccal Film, Compared to Placebo for treatment-resistant depression
This study is recruiting in the United States, in Australia, in Canada, .... It is testing VLS-01 Buccal Film, Compared to Placebo for treatment-resistant depression.
In United StatesDepressionOtherFrom 18 Years to 65 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.